SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.375
+0.145 (3.43%)
Oct 15, 2025, 2:30 PM EDT - Market open
SOPHiA GENETICS Revenue
SOPHiA GENETICS had revenue of $18.32M in the quarter ending June 30, 2025, with 15.91% growth. This brings the company's revenue in the last twelve months to $69.69M, up 7.31% year-over-year. In the year 2024, SOPHiA GENETICS had annual revenue of $65.17M with 4.49% growth.
Revenue (ttm)
$69.69M
Revenue Growth
+7.31%
P/S Ratio
4.05
Revenue / Employee
$164,747
Employees
423
Market Cap
295.66M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 65.17M | 2.80M | 4.49% |
Dec 31, 2023 | 62.37M | 14.81M | 31.14% |
Dec 31, 2022 | 47.56M | 7.11M | 17.58% |
Dec 31, 2021 | 40.45M | 12.05M | 42.43% |
Dec 31, 2020 | 28.40M | 3.04M | 11.98% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SOPH News
- 22 days ago - Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy - PRNewsWire
- 22 days ago - Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy - GlobeNewsWire
- 23 days ago - SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer - PRNewsWire
- 5 weeks ago - SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology - PRNewsWire
- 2 months ago - SOPHiA GENETICS SA (SOPH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - SOPHiA GENETICS Reports Second Quarter 2025 Results - PRNewsWire
- 2 months ago - SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes - PRNewsWire
- 3 months ago - SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025 - PRNewsWire